Intellia Therapeutics, Inc. (NTLA)
12.26
+0.14
(+1.16%)
USD |
NASDAQ |
Oct 02, 16:00
12.16
-0.10
(-0.82%)
After-Hours: 20:00
Intellia Therapeutics Price to Book Value : 2.359 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.359 |
| October 01, 2026 | 2.332 |
| September 30, 2026 | 2.320 |
| September 29, 2026 | 2.315 |
| September 28, 2026 | 2.197 |
| September 25, 2026 | 2.261 |
| September 24, 2026 | 2.340 |
| September 23, 2026 | 2.372 |
| September 22, 2026 | 2.442 |
| September 21, 2026 | 2.351 |
| September 18, 2026 | 2.336 |
| September 17, 2026 | 2.359 |
| September 16, 2026 | 2.211 |
| September 15, 2026 | 2.186 |
| September 14, 2026 | 2.284 |
| September 11, 2026 | 2.259 |
| September 10, 2026 | 2.296 |
| September 09, 2026 | 2.349 |
| September 08, 2026 | 2.451 |
| September 04, 2026 | 2.451 |
| September 03, 2026 | 2.440 |
| September 02, 2026 | 2.455 |
| September 01, 2026 | 2.441 |
| August 31, 2026 | 2.449 |
| August 28, 2026 | 2.476 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.522 |
| August 26, 2026 | 2.538 |
| August 25, 2026 | 2.600 |
| August 24, 2026 | 2.417 |
| August 21, 2026 | 2.471 |
| August 20, 2026 | 2.394 |
| August 19, 2026 | 2.555 |
| August 18, 2026 | 2.232 |
| August 17, 2026 | 2.326 |
| August 14, 2026 | 2.292 |
| August 13, 2026 | 2.276 |
| August 12, 2026 | 2.326 |
| August 11, 2026 | 2.313 |
| August 10, 2026 | 2.313 |
| August 07, 2026 | 2.297 |
| August 06, 2026 | 2.163 |
| August 05, 2026 | 2.111 |
| August 04, 2026 | 2.178 |
| August 03, 2026 | 2.072 |
| July 31, 2026 | 2.055 |
| July 30, 2026 | 2.134 |
| July 29, 2026 | 2.078 |
| July 28, 2026 | 2.095 |
| July 27, 2026 | 2.053 |
| July 24, 2026 | 2.065 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.370 |
| Twist Bioscience Corp. | 26.53 |
| Prime Medicine, Inc. | 13.53 |
| Moderna, Inc. | 11.21 |
| Q32 Bio, Inc. | 1.845 |
Price to Book Value Related Metrics
| PS Ratio | 24.62 |
| Price | 12.26 |
| Earnings Yield | -27.38% |
| Market Cap | 1.717B |